I have been given the opportunity

of a lifetime to help others.

FIGHT41CURE

Each year The Leukemia & Lymphoma Society (LLS) launches its Man & Woman of the Year fundraising campaign, and I was honored to join this year’s efforts as a

2021 Woman of the Year candidate. 

 

I ask for your support of LLS’s mission in its efforts to find cures for blood cancers and to assist patients and families

as they battle this disease.

There are many reasons to be proud to support LLS’s efforts.  For instance, of the 39 new cancer-fighting drugs approved by the F.D.A  in the past 10 years, 19 of them were initially developed for blood cancers and many had funding from LLS.  Of those 19, ALL of them show promise for treating other cancers:

LLS 2020 total.jpg
Gleevec

Used for patients with chronic myelogenous leukemia (CML), was recently approved to treat stomach ulcers and is in trials for breast, prostate and ovarian cancer treatments.

Velcade

That targeted drug to treat patients with myeloma or mantle cell lymphoma, is also in trials for people with kidney, lung and thyroid cancers.

Rituxan

The first approved targeted cancer drug that was initially used for non-Hodgkin lymphoma patients, is used in 11 blood cancer and rheumatoid arthritis treatments.

This is an organization that is doing the right things with the dollars it raises, and I’m proud to be associated with LLS.